Rubicon Organics Inc.
ROMJ.VTSXVHealthcare● Active
$0.44
+$0.01(+1.15%)
Market Cap$29557352
P/E Ratio—
52W High$0.73
52W Low$0.37
Rubicon Organics Inc. (ROMJ.V) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ROMJ.V · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.04
Est. -$0.03 · -50.0%
Revenue
$0.01B
Est. $0.01B · -4.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
ROMJ.V reports quarterly as a TSXV-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.01 | — | — | — | $0.02B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.03 | -$0.04 | -50.0% | $0.01B | $0.01B | -4.5% |
| ▼ Q1 FY2026 | Mar 24, 2026 | $0.01 | -$0.03 | -400.0% | $0.02B | $0.02B | +4.1% |
| ▲ Q3 FY2025 | Aug 18, 2025 | $0.01 | $0.01 | +16.9% | $0.01B | $0.01B | +16.2% |
| — Q2 FY2025 | May 27, 2025 | — | -$0.01 | — | $0.01B | $0.01B | -0.2% |
| — Q1 FY2025 | Mar 25, 2025 | — | -$0.00 | — | $0.01B | $0.01B | +3.6% |
| — Q4 FY2024 | Nov 13, 2024 | — | -$0.00 | — | $0.01B | $0.01B | -1.5% |
| — Q3 FY2024 | Aug 15, 2024 | — | -$0.01 | — | $0.01B | $0.01B | +21.1% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.04
EPS Est.
-$0.03
EPS Surpr.
-50.0%
Revenue
$0.01B
Q1 FY2026
Mar 24, 2026Miss
EPS Actual
-$0.03
EPS Est.
$0.01
EPS Surpr.
-400.0%
Revenue
$0.02B
Q3 FY2025
Aug 18, 2025Beat
EPS Actual
$0.01
EPS Est.
$0.01
EPS Surpr.
+16.9%
Revenue
$0.01B
Q2 FY2025
May 27, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 25, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2024
Aug 15, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -50.0% | $0.50 | $0.46 | -7.07% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -400.0% | $0.49 | $0.48 | -3.06% |
| ▲ Q3 FY2025 | Aug 18, 2025 | +16.9% | $0.54 | $0.52 | -3.70% |
| — Q2 FY2025 | May 27, 2025 | — | $0.40 | $0.40 | +0.00% |
| — Q1 FY2025 | Mar 25, 2025 | — | $0.50 | $0.54 | +8.00% |
| — Q4 FY2024 | Nov 13, 2024 | — | $0.36 | $0.36 | +0.00% |
| — Q3 FY2024 | Aug 15, 2024 | — | $0.46 | $0.44 | -4.35% |
| — Q2 FY2024 | May 16, 2024 | — | $0.55 | $0.39 | -30.00% |
Q2 FY2026-7.07%
Report Date
May 14, 2026
EPS Beat/Miss
-50.0%
Price Before
$0.50
Price After
$0.46
Q1 FY2026-3.06%
Report Date
Mar 24, 2026
EPS Beat/Miss
-400.0%
Price Before
$0.49
Price After
$0.48
Q3 FY2025-3.70%
Report Date
Aug 18, 2025
EPS Beat/Miss
+16.9%
Price Before
$0.54
Price After
$0.52
Q2 FY2025+0.00%
Report Date
May 27, 2025
EPS Beat/Miss
—
Price Before
$0.40
Price After
$0.40
Q1 FY2025+8.00%
Report Date
Mar 25, 2025
EPS Beat/Miss
—
Price Before
$0.50
Price After
$0.54
Q4 FY2024+0.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
—
Price Before
$0.36
Price After
$0.36
Q3 FY2024-4.35%
Report Date
Aug 15, 2024
EPS Beat/Miss
—
Price Before
$0.46
Price After
$0.44
Q2 FY2024-30.00%
Report Date
May 16, 2024
EPS Beat/Miss
—
Price Before
$0.55
Price After
$0.39
Avg Beat Reaction-3.70%
Avg Miss Reaction-5.07%
Beat Rate1 / 8 quarters
Largest Move-30.00% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ROMJ.V ends December
Rubicon Organics Inc. (ROMJ.V) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.04 — missing the analyst consensus of $-0.03 by -50.0%. The next ROMJ.V earnings date is expected around September 1, 2026.
Each quarter, investors track ROMJ.V earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ROMJ.V revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ROMJ.V's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ROMJ.V earnings · 5 questionsRubicon Organics Inc.'s next earnings report is expected around September 1, 2026. ROMJ.V typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ROMJ.V historically reports after market close (AMC).
ROMJ.V earnings datewhen is ROMJ.V earningsROMJ.V next earnings datewhen does ROMJ.V report earningsROMJ.V earnings calendar
▸ Source: FMP · Rubicon Organics Inc. SEC filings · US GAAP · Rubicon Organics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026